Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours

M Arena, E Masci, LH Eusebi, G Iabichino, B Mangiavillano, P Viaggi, E Morandi, Lorella Fanti, A Granata, M Traina, PA Testoni, E Opocher, C Luigiano

Research output: Contribution to journalArticle


Background Hemospray is a new endoscopic haemostatic powder that can be used in the management of upper gastrointestinal bleedings. Aims To assess the efficacy and safety of Hemospray as monotherapy for the treatment of acute upper gastrointestinal bleeding due to cancer. Methods The endoscopy databases of 3 Italian Endoscopic Units were reviewed retrospectively and 15 patients (8 males; mean age 74 years) were included in this study. Results Immediate haemostasis was achieved in 93% of cases. Among the successful cases, 3 re-bled, one case treated with Hemospray and injection had a good outcome, while 2 cases died both re-treated with Hemospray, injection and thermal therapy. No complications related to Hemospray occurred. Finally, 80% of patients had a good clinical outcome at 30 days and 50% at six months. Conclusion Hemospray may be considered an effective and safe method for the endoscopic management of acute neoplastic upper gastrointestinal bleedings. © 2016 Editrice Gastroenterologica Italiana S.r.l.
Original languageEnglish
Pages (from-to)514-517
Number of pages4
JournalDigestive and Liver Disease
Issue number5
Publication statusPublished - 2017


Cite this

Arena, M., Masci, E., Eusebi, LH., Iabichino, G., Mangiavillano, B., Viaggi, P., Morandi, E., Fanti, L., Granata, A., Traina, M., Testoni, PA., Opocher, E., & Luigiano, C. (2017). Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours. Digestive and Liver Disease, 49(5), 514-517. https://doi.org/10.1016/j.dld.2016.12.012